Additional Information
Level of Instruction: Intermediate
Intended Audience: This course is for molecular biology bench technicians, technologists, supervisors, and administrators. This course is also appropriate for molecular biology students, medical laboratory science students, and pathology residents.
Author Information: Tabetha Sundin, PhD, HCLD(ABB), MB(ASCP)CM, has over 10 years of laboratory experience in cancer biology and clinical molecular diagnostics. She is the Scientific Director of Molecular Diagnostics and Serology at Sentara Healthcare. Dr. Sundin has served as a Speaker for AstraZeneca and Bristol-Myers Squibb, covering multidisciplinary facilitation of biomarker testing in cancer patients. She has been an active member of the Association of Molecular Pathology (AMP). She is involved with numerous efforts to support the molecular diagnostics field with American Medical Technologists (AMT) and the Clinical & Laboratory Standards Institute (CLSI).
The author has no conflict of interest to disclose.
Reviewer Information:
Laurie Bjerklie, MA, MLS(ASCP)CM, is
a Lead Education Developer. She earned a B.S. in Medical Laboratory Science
from the University of North Dakota and an M.A. in Curriculum and Instruction
from Saint Xavier University. She has over 15 years of experience in higher
education and has held program director and faculty positions in both MLT and
MLS programs.
Kevin F. Foley, PhD, DABCC, MLS, SC, is the Northwest chemistry, toxicology, immunology, and POC director for Kaiser Permanente. He also teaches pharmacology, clinical chemistry, immunology, and medicinal chemistry at Oregon Health Sciences University. Dr. Foley earned his PhD in clinical pharmacology and toxicology at the East Carolina School of Medicine in North Carolina. His research areas include cardiovascular risk and inflammation markers, as well as the neuropharmacology of amphetamine-like compounds. He frequently contributes to several clinical laboratory publications and is active in the American Association of Clinical Chemistry.
Course Description: This course covers some basic genetic principles and how changes to the genetic code can lead to carcinogenesis. It also addresses how molecular diagnostics aid personalized medicine in matching the patient with the correct targeted therapy.
